Dr. Anadkat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Forest Park Ave
# Dv
Saint Louis, MO 63108Phone+1 314-273-3376Fax+1 888-665-8309
Summary
- Dr. Milan Anadkat is a dermatologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from Northeast Ohio Medical University and has been in practice 16 years. He is experienced in general and complex medical dermatology, chemotherapy related skin toxicity, autoimmune bulls disease, hidradenitis, and graft-versus-host disease.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2004 - 2007
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
- Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
- MO State Medical License 2002 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash Start of enrollment: 2008 Apr 03
- A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
- Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Start of enrollment: 2026 Jan 01
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsInitial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus GuidelinesLauren D. Crow, Anokhi Jambusaria-Pahlajani, Christina L. Chung, David A. Baran, Stefan E. Lowenstein
Transplant International. 2019-12-01 - 642 citationsManagement of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.Bryan J. Schneider, Jarushka Naidoo, Bianca Santomasso, Christina Lacchetti, Sherry Adkins
Journal of Clinical Oncology. 2021-11-01 - 21 citationsEfficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, pl...Akimichi Morita, Bruce Strober, A David Burden, Siew Eng Choon, Milan J Anadkat
Lancet. 2023-10-28
Journal Articles
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseKarl M Saardi, Rachel K Rosenstein, Milan J Anadkat, JAMA Dermatology
Lectures
- Dermatologic Findings in the Stem Cell Transplant PatientAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
- Inflammatory Bowel Disease 2013Washington University School of Medicine, Saint Louis, Missouri - 6/8/2013
- Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual MeetingFlorida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012
Authored Content
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseMay 2020
Press Mentions
- Study Adds Evidence on the Link Between Leukemia Cutis and Poor Prognosis in AMLMay 6th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: